EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Model‐Informed Vancomycin Dosing Optimization to Address Delayed Renal Maturation in Infants and Young Children with Critical Congenital Heart Disease

Yuko Shimamoto, Keizo Fukushima, Tomoyuki Mizuno iD, Hajime Ichikawa, Kenichi Kurosaki, Shinichiro Maeda, Masahiro Okuda

Clinical Pharmacology & Therapeutics · 2024

DOI: 10.1002/cpt.3095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2024. Verfasst von Yuko Shimamoto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan. Hauptthemen laut MEDLINE: Vancomycin, Heart Defects, Congenital. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ensuring safe and effective drug therapy in infants and young children often requires accounting for growth and organ development; however, data on organ function maturation are scarce for special populations, such as infants with congenital diseases. Children with critical congenital heart disease (CCHD) often require multiple staged surgeries depending on their age and disease severity. Vancomycin (VCM) is used to treat postoperative infections; however, the standard pediatric dose (60–80 mg/kg/day) frequently results in overexposure in children with CCHD. In this study, we characterized the maturation of VCM clearance in pediatric patients with CCHD and determined the appropriate dosing regimen using population pharmacokinetic (PK) modeling and simulations. We analyzed 1,254 VCM serum concentrations from 152 postoperative patients (3 days–13 years old) for population PK analysis. The PK model was developed using a two‐compartment model with allometrically scaled body weight, estimated glomerular filtration rate (eGFR), and postmenstrual age as covariates. The observed clearance in patients aged ≤ 1 year and 1–2 years was 33% and 40% lower compared with that of non‐CCHD patients, respectively, indicating delayed renal maturation in patients with CCHD. Simulation analyses suggested VCM doses of 25 mg/kg/day (age ≤ 3 months, eGFR 40 mL/min/1.73 m 2 ) and 35 mg/kg/day (3 months < age ≤ 3 years, eGFR 60 mL/min/1.73 m 2 ). In conclusion, this study revealed delayed renal maturation in children with CCHD, could be due to cyanosis and low cardiac output. Model‐informed simulations identified the lower VCM doses for children with CCHD compared with standard pediatric guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinHeart Defects, CongenitalInfantHumansChildChild, PreschoolAnti-Bacterial AgentsKidneyGlomerular Filtration Rate

Substanzen

VancomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmacy, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
  • Department of Hospital Pharmacy, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
  • Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
  • Department of Pediatric Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
  • Department of Pediatric Cardiology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

ORCID-Profile: Tomoyuki Mizuno

Zitieren

APA

Shimamoto, Y., Fukushima, K., Mizuno, T., Ichikawa, H., Kurosaki, K., Maeda, S., & Okuda, M. (2024). Model‐Informed Vancomycin Dosing Optimization to Address Delayed Renal Maturation in Infants and Young Children with Critical Congenital Heart Disease. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3095

Vancouver

Shimamoto Y, Fukushima K, Mizuno T, Ichikawa H, Kurosaki K, Maeda S, et al. Model‐Informed Vancomycin Dosing Optimization to Address Delayed Renal Maturation in Infants and Young Children with Critical Congenital Heart Disease. Clinical Pharmacology & Therapeutics. 2024. doi:10.1002/cpt.3095

BibTeX
@article{Shimamoto2024,
  author = {Shimamoto, Yuko and Fukushima, Keizo and Mizuno, Tomoyuki and Ichikawa, Hajime and Kurosaki, Kenichi and Maeda, Shinichiro and Okuda, Masahiro},
  title = {Model‐Informed Vancomycin Dosing Optimization to Address Delayed Renal Maturation in Infants and Young Children with Critical Congenital Heart Disease},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2024},
  doi = {10.1002/cpt.3095}
}
Kostenlos starten →